Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 7
1999 5
2000 6
2001 10
2002 3
2003 3
2004 1
2005 6
2006 4
2007 4
2008 1
2009 8
2010 7
2011 11
2012 10
2013 8
2014 11
2015 21
2016 19
2017 28
2018 28
2019 22
2020 28
2021 24
2022 37
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

265 results
Results by year
Filters applied: . Clear all
Page 1
Quantitative Clinical Pharmacology of CAR T-Cell Therapy.
Holstein SA, Venkatakrishnan K, van der Graaf PH. Holstein SA, et al. Among authors: venkatakrishnan k. Clin Pharmacol Ther. 2022 Jul;112(1):11-15. doi: 10.1002/cpt.2631. Clin Pharmacol Ther. 2022. PMID: 35716389 No abstract available.
Triterpenoids and polysaccharide peptides-enriched Ganoderma lucidum: a randomized, double-blind placebo-controlled crossover study of its antioxidation and hepatoprotective efficacy in healthy volunteers.
Chiu HF, Fu HY, Lu YY, Han YC, Shen YC, Venkatakrishnan K, Golovinskaia O, Wang CK. Chiu HF, et al. Among authors: venkatakrishnan k. Pharm Biol. 2017 Dec;55(1):1041-1046. doi: 10.1080/13880209.2017.1288750. Pharm Biol. 2017. PMID: 28183232 Free PMC article. Clinical Trial.
Reverse Translation: The Art of Cyclical Learning.
Kasichayanula S, Venkatakrishnan K. Kasichayanula S, et al. Among authors: venkatakrishnan k. Clin Pharmacol Ther. 2018 Feb;103(2):152-159. doi: 10.1002/cpt.952. Clin Pharmacol Ther. 2018. PMID: 29313963
Pharmacometrics Golems: Exposure-Response Models in Oncology.
Khandelwal A, Grisic AM, French J, Venkatakrishnan K. Khandelwal A, et al. Among authors: venkatakrishnan k. Clin Pharmacol Ther. 2022 Nov;112(5):941-945. doi: 10.1002/cpt.2564. Epub 2022 Mar 14. Clin Pharmacol Ther. 2022. PMID: 35286713 No abstract available.
Model-Informed Drug Development for Ixazomib, an Oral Proteasome Inhibitor.
Gupta N, Hanley MJ, Diderichsen PM, Yang H, Ke A, Teng Z, Labotka R, Berg D, Patel C, Liu G, van de Velde H, Venkatakrishnan K. Gupta N, et al. Among authors: venkatakrishnan k. Clin Pharmacol Ther. 2019 Feb;105(2):376-387. doi: 10.1002/cpt.1047. Epub 2018 Mar 23. Clin Pharmacol Ther. 2019. PMID: 29446068 Free PMC article. Review.
265 results